New Approach Methods (NAMs) Supporting Read-Across: Two Neurotoxicity AOP-based IATA Case Studies

被引:18
|
作者
van der Stel, Wanda [1 ]
Carta, Giada [2 ]
Eakins, Julie [3 ]
Delp, Johannes [4 ]
Suciu, Ilinca [4 ,5 ]
Forsby, Anna [6 ]
Cediel-Ulloa, Andrea [7 ]
Attoff, Kristina [6 ]
Troger, Florentina [8 ]
Kamp, Hennicke [9 ]
Gardner, Iain [10 ]
Zdrazil, Barbara [8 ]
Mone, Martijn J. [1 ]
Ecker, Gerhard F. [8 ]
Pastor, Manuel [11 ]
Gomez-Tamayo, Jose Carlos [11 ]
White, Andrew [12 ]
Danen, Erik H. J. [1 ]
Leist, Marcel [4 ]
Walker, Paul [3 ]
Jennings, Paul [2 ]
Bennekou, Susanne Hougaard [13 ]
van de Water, Bob [1 ]
机构
[1] Leiden Univ, Leiden Acad Ctr Drug Res, Div Drug Discovery & Safety, Leiden, Netherlands
[2] Vrije Univ Amsterdam, Dept Chem & Pharmaceut Sci, Div Mol & Computat Toxicol, AIMMS, Amsterdam, Netherlands
[3] Cyprotex Discovery Ltd, Alderley Pk, Macclesfield, Cheshire, England
[4] Univ Konstanz, Dept Inaugurated Doerenkamp Zbinden Fdn, Chair In Vitro Toxicol & Biomed, Constance, Germany
[5] Univ Konstanz, Konstanz Res Sch Chem Biol, Constance, Germany
[6] Stockholm Univ, Dept Biochem & Biophys, Stockholm, Sweden
[7] Uppsala Univ, Dept Organismal Biol, Uppsala, Sweden
[8] Univ Vienna, Dept Pharmaceut Chem, Vienna, Austria
[9] BASF, Ludwigshafen, Germany
[10] Certara UK Ltd, Sheffield, S Yorkshire, England
[11] Univ Pompeu Fabra, Dept Expt & Hlth Sci, Barcelona, Spain
[12] Unilever, Sharnbrook, Beds, England
[13] Tech Univ Denmark DTU, Natl Food Inst, Lyngby, Denmark
关键词
COMPLEX III DEFICIENCY; ADVERSE OUTCOME PATHWAY; NITRIC-OXIDE; MITOCHONDRIAL; PHARMACOKINETICS; DEGUELIN; NEURONS; VOLUME;
D O I
10.14573/altex.2103051
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Read-across approaches are considered key in moving away from in vivo animal testing towards addressing data-gaps using new approach methods (NAMs). Ample successful examples are still required to substantiate this strategy. Here we present and discuss the learnings from two OECD IATA endorsed read-across case studies. They involve two classes of pesticides - rotenoids and strobilurins - each having a defined mode-of-action that is assessed for its neurological hazard by means of an AOP-based testing strategy coupled to toxicokinetic simulations of human tissue concentrations. The endpoint in question is potential mitochondrial respiratory chain mediated neurotoxicity, specifically through inhibition of complex I or III. An AOP linking inhibition of mitochondrial respiratory chain complex I to the degeneration of dopaminergic neurons formed the basis for both cases but was deployed in two different regulatory contexts. The two cases also exemplify several different read-across concepts: analogue versus category approach, consolidated versus putative AOP, positive versus negative prediction (i.e., neurotoxicity versus low potential for neurotoxicity), and structural versus biological similarity. We applied a range of NAMs to explore the toxicodynamic properties of the compounds, e.g., in silico docking as well as in vitro assays and readouts - including transcriptomics - in various cell systems, all anchored to the relevant AOPs. Interestingly, although some of the data addressing certain elements of the read-across were associated with high uncertainty, their impact on the overall read-across conclusion remained limited. Coupled to the elaborate regulatory review that the two cases underwent, we propose some generic learnings of AOP-based testing strategies supporting read-across.
引用
收藏
页码:615 / 635
页数:21
相关论文
共 22 条
  • [1] Two read-across case studies using IATA approach focused on biological similarity
    Okamoto, M.
    Nakagawa, S.
    Nukada, Y.
    Morita, O.
    TOXICOLOGY LETTERS, 2019, 314 : S139 - S139
  • [2] Learnings from EU-ToxRisk read-across case studies: application of new approach methods
    van de Water, B.
    TOXICOLOGY LETTERS, 2019, 314 : S28 - S28
  • [3] Integration of new approach methods in a structure based read-across for DART effects
    Kroese, E. D.
    Brotzmann, K.
    Koch, B.
    Waldmann, T.
    Kisitu, J.
    Jaklin, M.
    van Vugt, B.
    Fisher, C.
    Bois, F. Y.
    Simeon, S.
    Long, T.
    Norinder, U.
    van der Burg, B.
    Wolterbeek, A.
    TOXICOLOGY LETTERS, 2019, 314 : S27 - S28
  • [4] Incorporating lines of evidence from New Approach Methodologies (NAMs) to reduce uncertainties in a category based read-across: A case study for repeated dose toxicity
    Pestana, Cynthia B.
    Firman, James W.
    Cronin, Mark T. D.
    REGULATORY TOXICOLOGY AND PHARMACOLOGY, 2021, 120
  • [5] Read-across case studies to implement new approaches for hazard assessment
    Escher, S. E.
    TOXICOLOGY LETTERS, 2023, 384 : S21 - S21
  • [6] EU-ToxRisk guidance for New Approach Methods (NAM)-supported Read-Across
    Kamp, H.
    Bennekou, S. Hougaard
    Bitsch, A.
    Escher, S.
    Kroese, D.
    Mone, M.
    Ouedraogo, G.
    Stuart, S.
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2020, 393 (SUPPL 1) : 91 - 91
  • [7] Integrate mechanistic evidence from new approach methodologies (NAMs) into a read-across assessment to characterise trends in shared mode of action
    Escher, Sylvia E.
    Aguayo-Orozco, Alejandro
    Benfenati, Emilio
    Bitsch, Annette
    Braunbeck, Thomas
    Brotzmann, Katharina
    Bois, Frederic
    van der Burg, Bart
    Castel, Jose
    Exner, Thomas
    Gadaleta, Domenico
    Gardner, Iain
    Goldmann, Daria
    Hatley, Oliver
    Golbamaki, Nazanin
    Graepel, Rabea
    Jennings, Paul
    Limonciel, Alice
    Long, Anthony
    Maclennan, Richard
    Mombelli, Enrico
    Norinder, Ulf
    Jain, Sankalp
    Capinha, Liliana Santos
    Taboureau, Olivier T.
    Tolosa, Laia
    Vrijenhoek, Nanette G.
    Van Vugt-Lussenburg, Barbara M. A.
    Walker, Paul
    van de Water, Bob
    Wehr, Matthias
    White, Andrew
    Zdrazil, Barbara
    Fisher, Ciaran
    TOXICOLOGY IN VITRO, 2022, 79
  • [8] Use of new approach methods to support chemical read-across: the EU-ToxRisk experience
    van de Water, B.
    Kamp, H.
    Escher, S.
    Kroese, D.
    TOXICOLOGY LETTERS, 2018, 295 : S10 - S10
  • [9] Advancing the science of a read-across framework for evaluation of data-poor chemicals incorporating systematic and new approach methods
    Lizarraga, Lucina E.
    Suter, Glenn W.
    Lambert, Jason C.
    Patlewicz, Grace
    Zhao, Jay Q.
    Dean, Jeffry L.
    Kaiser, Phillip
    REGULATORY TOXICOLOGY AND PHARMACOLOGY, 2023, 137
  • [10] Assessing uncertainty in read-across: Questions to evaluate toxicity predictions based on knowledge gained from case studies
    Schultz T.W.
    Richarz A.-N.
    Cronin M.T.D.
    Computational Toxicology, 2019, 9 : 1 - 11